FRI596 Randomized Clinical Trial Of Theophylline For Treatment Of Pseudohypoparathyroidism Type 1a

Disclosure: A.H. Shoemaker: None. J. Tamaroff: None. H. Jueppner: None. Background: Pseudohypoparathyroidism type 1A (PHP1A) is a rare, genetic disorder caused by heterozygous inactivating mutations involving the maternal GNAS allele, the gene that encodes the stimulatory G protein (Gsα). Due to tis...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoemaker, Ashley Hall, Tamaroff, Jaclyn, Jueppner, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553654/
http://dx.doi.org/10.1210/jendso/bvad114.1503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553654/
http://dx.doi.org/10.1210/jendso/bvad114.1503

Ejemplares similares